Treatment of Nail Bed Infections
Immediate Diagnostic Imperative
Treatment should never be initiated without first distinguishing between bacterial and fungal nail bed infections, as they require fundamentally different therapeutic approaches. 1
Clinical Differentiation
Bacterial infections present with:
- Acute onset with significant pain, erythema, and warmth 1
- Purulent drainage or abscess formation 2, 1
- Rapid progression over days 3
Fungal infections (onychomycosis) present with:
- Gradual onset with minimal pain 1
- Nail discoloration, thickening, and dystrophic changes 4
- Chronic progression over months 5
Mandatory Culture Collection
Obtain bacterial or fungal cultures before initiating therapy to guide appropriate treatment, especially if purulent material is present. 2, 1
Treatment Algorithm for Bacterial Nail Bed Infections
Step 1: Drainage First
If an abscess or subungual hematoma is present, drainage is mandatory before antibiotic therapy. 1 Partial or total nail avulsion may be required for adequate drainage. 2, 1
Step 2: First-Line Antibiotic Selection
For mild to moderate bacterial nail bed infections, cephalexin is the recommended first-line antibiotic, targeting Staphylococcus aureus and Streptococcus pyogenes. 1
Alternative oral antibiotics include:
Step 3: Adjunctive Wound Care
- Daily dilute vinegar soaks to reduce inflammation 2
- Keep the affected area clean and dry between soaks 1
- Apply mid to high potency topical steroid ointment to reduce edema 2
- Avoid manipulation of cuticles and nail biting 1
Step 4: Follow-Up Assessment
Reassess after 2 weeks of treatment. 2, 1 If infection worsens or fails to improve, consider:
Treatment Algorithm for Fungal Nail Bed Infections (Onychomycosis)
Dermatophyte Infections (Most Common)
Terbinafine 250 mg daily is the preferred first-line treatment for dermatophyte onychomycosis. 1
Treatment duration:
Alternative first-line option:
- Itraconazole pulse therapy: 200 mg twice daily for 1 week per month 1
Baseline monitoring: Obtain liver function tests and complete blood count before initiating terbinafine. 1
Candida Nail Infections
Azole antifungals are advocated when onychomycosis is caused by Candida species. 4
- Fluconazole 150-450 mg weekly for 3 months or longer 1
- Itraconazole is equally effective for Candida infections 4
Topical Therapy Considerations
Topical agents (amorolfine, ciclopirox) may be appropriate for:
- Mild to moderate infections 4
- Patients with high risk of drug interactions 4
- Infections involving less than 50% of the nail plate 5
However, topical therapy alone is generally insufficient for most nail bed infections requiring systemic treatment. 4, 5
Mechanical Intervention
Remove dermatophytomas mechanically, as these fungal masses within the nail plate or nail bed can be resistant to antifungal treatment alone. 4, 1
Special Population Considerations
Diabetic Patients
Terbinafine is the oral antifungal agent of choice in diabetic patients due to low risk of drug interactions and hypoglycemia. 4
- Onychomycosis is a significant predictor for foot ulcer development in diabetes 4
- Itraconazole is contraindicated in congestive heart failure, which has increased prevalence in diabetics 4
- Topical treatments are appropriate for mild-to-moderate infections where drug interaction risk is high 4
Immunosuppressed Patients
Terbinafine and fluconazole are preferred for onychomycosis in HIV-positive patients and those on immunosuppressive therapy. 4
- Itraconazole and ketoconazole have increased risk of interactions with antiretrovirals 4
- Griseofulvin is the least effective oral antifungal in immunosuppressed patients 4
Critical Pitfalls to Avoid
Do not use prophylactic antibiotics for clean puncture wounds without signs of infection. 2
Do not initiate treatment based on clinical appearance alone—always confirm diagnosis with microscopy and culture. 4
Do not use terbinafine for Candida onychomycosis, as it has limited and unpredictable activity against yeasts. 4
Do not prescribe inadequate duration of therapy, as this leads to recurrence and potential resistance. 1
Do not confuse herpetic whitlow (viral) with bacterial abscess—the former requires non-operative treatment to prevent sequelae. 3